MNTA: Is there any way to gauge how the FDA will respond to the generic Lovenox applicants? In particular who is notified first? Would they be inclined to announce a denial first before an approval or vice versa. If TEVA were to find out they got denied before MNTA was notified of an approval/denial would MNTA share price go up or down?
I'm sort of extended on MNTA on margin believing they will hear an approval before TEVA's denial ; )